Publication Name	World Journal of Gastroenterology
Manuscript ID	93046
Country	China

Received	2024-02-19 07:59
Peer-Review Started	2024-02-19 07:59
To Make the First Decision
Return for Revision	2024-03-07 00:51
Revised	2024-03-25 13:05
Second Decision	2024-04-09 03:14
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-04-09 03:34
Articles in Press	2024-04-09 03:34
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-04-25 01:59
Publish the Manuscript Online	2024-05-05 10:12

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Retrospective Study
Article Title	Efficacy and safety of targeted therapy plus immunotherapy combined with hepatic artery infusion chemotherapy (FOLFOX) for unresectable hepatocarcinoma
Manuscript Source	Unsolicited Manuscript
All Author List	Zhi-Peng Lin, Xiao-Long Hu, Du Chen, Da-Bei Huang, Xu-Gong Zou, Hai Zhong, Sheng-Xiang Xu, Yuan Chen, Xiao-Qun Li and Jian Zhang
Funding Agency and Grant Number
Corresponding Author	Jian Zhang, Doctor, Associate Chief Physician, Department of Interventional Medicine, Zhongshan People’s Hospital, No. 2 Sun Wen East Road, Zhongshan 528400, Guangdong Province, China. wy18988583838@163.com
Key Words	Hepatocellular carcinoma; Hepatic arterial infusion chemotherapy; Targeted therapy; Immunotherapy; Adverse events
Core Tip	The therapeutic strategy of combining multiple modes of drug delivery for the treatment of hepatocellular carcinoma (HCC) has been shown to be more efficacious than single treatment modality, but the underlying mechanism of action has not been clarified. In this study, we observed the clinical efficacy of targeted therapy plus immunotherapy combined with FOLFOX hepatic artery infusion chemotherapy in the treatment of unresectable HCC, which provides a clinical basis for the clinical application of the combination of therapy in HCC.
Publish Date	2024-05-05 10:12
Citation	<p>Lin ZP, Hu XL, Chen D, Huang DB, Zou XG, Zhong H, Xu SX, Chen Y, Li XQ, Zhang J. Efficacy and safety of targeted therapy plus immunotherapy combined with hepatic artery infusion chemotherapy (FOLFOX) for unresectable hepatocarcinoma. <i>World J Gastroenterol</i> 2024; 30(17): 2321-2331</p>
URL	https://www.wjgnet.com/1007-9327/full/v30/i17/2321.htm
DOI	https://dx.doi.org/10.3748/wjg.v30.i17.2321

Full Article (PDF)	WJG-30-2321-with-cover.pdf
Manuscript File	93046_Auto_Edited-YJP.docx
Answering Reviewers	93046-Answering reviewers.pdf
Audio Core Tip	93046-Audio core tip.mp3
Biostatistics Review Certificate	93046-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	93046-Conflict-of-interest statement.pdf
Copyright License Agreement	93046-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s)	93046-Informed consent statement.pdf
Institutional Review Board Approval Form or Document	93046-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate	93046-Language certificate.pdf
Peer-review Report	93046-Peer-review(s).pdf
Scientific Misconduct Check	93046-Bing-Chen YL-2.png
Scientific Editor Work List	93046-Scientific editor work list.pdf
CrossCheck Report	93046-CrossCheck report.pdf